Opioid overdose antidote recalled over particulate matter
07 June, 2018, 19:37
A recall for naloxone was issued by the Food and Drug Administration over fear that products from the company Hospira Inc. contain potentially unsafe loose particles.
To date, no injuries or other adverse reactions have been associated with the recall, FDA said. In the press release put out by the Food and Drug Administration, Hospira says that it is recalling lots 72680LL and 76510LL of Naloxone.
See the full recall details. People who have experienced adverse effects from the particulate matter should contact the FDA.
Exposure to these particulates could have adverse health effects on users of Naloxone.
Heinz Change Salad Cream Name After 104 Years The spokesman added: "As a market-leading business, Kraft Heinz continues to audit its portfolio to meet the needs of consumers". You'd be hard pressed to find a household in Britain that doesn't have a bottle of Salad Cream at the back of the fridge.
A label on the product, distributed to hospitals and institutions, recommends "visual inspection of the product for particulate matter and discoloration prior to administration", which may reduce the risk of infection.
But with the opioid epidemic raging on, claiming tens of thousands of lives every day, the naloxone recall could hit particularly hard, if only temporarily.
Affected products are intended for intravenous (IV) use, intramuscular use and subcutaneous use only, FDA said. The drug is known to restore the respiration to a person who stops breathing due to the overdose. "Hospira, Inc., has notified wholesalers/distributors/hospitals to arrange for return of any recalled product".
According to CNN, the deliveries in question were sent to wholesalers, distributors, and hospitals in the United States, including Puerto Rico and Guam.